Brands: Letairis · Ambrisentan
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Pharmaceuticals USA Inc. | unknown | 10 | SUPPLYING |
| Gilead Sciences, Inc. | unknown | 10 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 10 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 8 | SUPPLYING |
| Cipla USA Inc. | unknown | 4 | SUPPLYING |
| Sigmapharm Laboratories, LLC | unknown | 4 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 3 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 2 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 2 | SUPPLYING |
| Quallent Pharmaceuticals Health LLC | unknown | 2 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Apotex Corp. | unknown | 2 | SUPPLYING |
No recalls, shortages, or registration changes on record for this drug concept.
Pill